𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genetic counseling and interpretation of genetic tests in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer

✍ Scribed by Nora Wong; Dana Lasko; Rogério Rabelo; Leonard Pinsky; Philip H. Gordon; William Foulkes

Publisher
Springer
Year
2001
Tongue
English
Weight
865 KB
Volume
44
Category
Article
ISSN
0012-3706

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical challenges in management of fam
Clinical challenges in management of familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer
✍ Patrick M. Lynch 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 2 views

A s of 1999, it is possible to test selected subjects for carriage of germline mutations in genes responsible for familial adenomatous polyposis (FAP), 1,2 hereditary nonpolyposis colorectal cancer (HNPCC), 3,4 Peutz-Jeghers syndrome, 5 and juvenile polyposis. 6,7 These diseases are heterogeneous ph

Genetic counseling in a navajo hereditar
Genetic counseling in a navajo hereditary nonpolyposis colorectal cancer kindred
✍ Henry T. Lynch; Tom Drouhard; Hans F. A. Vasen; Jennifer Cavalieri; Jane Lynch; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

## BACKGROUND. Cross-cultural genetic counseling was provided to an extended Navajo Indian family in which the MLHl gene mutation for hereditary nonpolyposis colorectal cancer (HNPCC) had been identified. The family had been observed by the authors since 1983 and over the years had been provided w

Hereditary nonpolyposis colorectal cance
Hereditary nonpolyposis colorectal cancer: Review of clinical, molecular genetics, and counseling aspects
✍ Bellacosa, Alfonso; Genuardi, Maurizio; Anti, Marcello; Viel, Alessandra; de Leo 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 3 views

Lynch syndrome, or hereditary nonpolyposis colon cancer (HNPCC), is an autosomaldominant disease accounting for approximately 1 5 % of all colorectal cancer cases. Due to the lack of pathognomonic morphological or biomolecular markers, HNPCC has traditionally posed unique problems to clinicians and